ClinicalTrials.gg
RecruitingNCT06299969FITT-OHCAUpdated Mar 8, 2024

Feedback Intervention and Treatment Trial in Patients With Out-of-Hospital Cardiac Arrest

An observational study in Out-Of-Hospital Cardiac Arrest, sponsored by St.Bernward Hospital. Recruiting at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-03-08.

Sponsored by St.Bernward Hospital · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as recruiting.
  • Started Jan 2023; still recruiting 3 years 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
3,000
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 13 studies in Out-of-Hospital Cardiac Arrest with a site in Germany — 5 open to participants now, 6 under way, none of them phase 3. Out-of-Hospital Cardiac Arrest · Germany.

Started
2023
with 2 others
Observational
6 of 13
3 open now
Registered
10th of 13
by date
Lead sponsor
1 of 13
St.Bernward Hospital

Among the 13 studies in Out-of-Hospital Cardiac Arrest with a site in Germany, this one is one of 3 that started in 2023, is one of 6 observational ones, and was the 10th registered.

Out-of-Hospital Cardiac Arrest

314 studies on the registry are indexed under Out-of-Hospital Cardiac Arrest; 93 are open to participants now.

Browse Out-of-Hospital Cardiac Arrest studies →

Open to participants now

5 of the 13 studies in Out-of-Hospital Cardiac Arrest with a site in Germany are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →

Who these studies take

Of the 66 Out-of-Hospital Cardiac Arrest studies recruiting now, 46 (70%) set no upper age limit and 13 (20%) stop at 75 or younger; 8 take children under 18; 7 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Out-of-Hospital Cardiac Arrest with a site in Germany, or all of them as a file.
02

Study summary

The trial collects and analyzes data from Cardiac Arrest Centres in patients with out-of-hospital cardiac arrest (OHCA).

Read the detailed description

With around 70,000 cases per year, out-of-hospital cardiac arrest (OHCA) is one of the most common causes of death in Germany. Only less than 10% of patients with an OHCA can currently be discharged with a satisfactory neurological outcome. The FITT-OHCA trial is a quality management project and collects data from Cardiac Arrest Centres on pre-hospital care and early post-resuscitation treatment in a standardized manner. The aim is to optimize the treatment process in patients following successful prehospital resuscitation through systematic data collection and feedback to the members of the rescue and treatment chain. The study includes cluster randomization of the participating hospitals.

03

Conditions studied

  • Out-Of-Hospital Cardiac Arrest

Keywords

  • OHCA
  • Out-of-hospital cardiac arrest
  • In-hospital cardiac arrest
  • Resuscitation
  • Cardiac arrest center
  • Feedback intervention
  • Acute care medicine
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients treated after out-of-hospital cardiac arrest

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients after cardiac arrest

Exclusion criteria

Exclusion Criteria:

  • refused register participation by patient or legal representative
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
3,000 participants (estimated)
Target follow-up
30 Days
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. In-hospital mortality

    Death/Survival at discharge

    Time frame: 3 weeks

Secondary outcomes

  1. CPC score

    Cerebral performance category

    Time frame: 3 weeks

  2. MRS

    Modified ranking scale

    Time frame: 3 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2023 (actual). Primary completion is estimated for Dec 2025, 35 months after the start.

Of 69 non-industry observational studies under Out-of-Hospital Cardiac Arrest, half reached primary completion within 46 months of starting (the median), counting those still running; a quarter within 20 and three quarters within 75. This study's planned 35 months is below that.

Counting every sponsor, half of 69 studies reached it within 46 months; a quarter within 20 and three quarters within 75.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 29, 2023
First posted
Mar 8, 2024
StartActual
Jan 1, 2023
Primary completionEst.
Dec 31, 2025
CompletionEst.
Dec 31, 2025
Last update
Mar 8, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 8, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06299969
Lead sponsor
St.Bernward Hospital
Collaborators
University Medical Center Goettingen
Responsible party
Karl Heinrich Scholz (Professor, St.Bernward Hospital) — Principal investigator
First posted
Mar 8, 2024
Start date
Jan 1, 2023
Primary completion
Dec 31, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Mar 8, 2024

Study contacts

Karl H Scholz, MD
Contact
k.scholz@fitt-stemi.de
+4955139 ext. 64940
Thomas Meyer, MD
Contact
thomas.meyer@med.uni-goettingen.de
+4955139 ext. 64940

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion